RXO, Inc. Deferred Income Tax Expense (Benefit) in USD from 2020 to Q1 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
RXO, Inc. quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from 2020 to Q1 2025.
- RXO, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2025 was -$11M, a 57.1% decline year-over-year.
- RXO, Inc. annual Deferred Income Tax Expense (Benefit) for 2024 was -$19M, a 138% decline from 2023.
- RXO, Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was -$8M, a 60% increase from 2022.
- RXO, Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was -$20M, a 767% decline from 2021.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Growth (%)